Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

miRNAs; a novel strategy for the treatment of COVID‐19

28 Jun 2021

Abstract excerpt

Coronavirus disease 2019 (COVID-19) is the seventh member of the bat severe acute respiratory syndrome family. COVID-19 can fuse their envelopes with the host cell membranes and deliver their genetic material. COVID-19 attacks the respiratory system and stimulates the host inflammatory responses, enhances the recruitment of immune cells, and promotes angiotensin-converting enzyme 2 activities. Patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Impact on Reproduction
Share to MicroRNA in disease regulation
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34180562
DOI: 10.1002/cbin.11653

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

miRNAs; a novel strategy for the treatment of COVID‐19PMID 34180562Read ↗

Role of microRNAs in COVID-19 with implications for therapeuticsSemantic proximity Read ↗

The Role of miRNAs in COVID-19 DiseaseSemantic proximity Read ↗

miRNAs, from Evolutionary Junk to Possible Prognostic Markers and Therapeutic Targets in COVID-19Semantic proximity Read ↗

Role of Mirnas As Biomarkers of Covid-19: A Scoping Review of the Status and Future Directions for Research in This FieldSemantic proximity Read ↗

MicroRNAs and SARS-CoV-2 life cycle, pathogenesis, and mutations: biomarkers or therapeutic agents?Semantic proximity Read ↗

MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19Semantic proximity Read ↗

Anti-SARS-CoV-2 Strategies and the Potential Role of miRNA in the Assessment of COVID-19 Morbidity, Recurrence, and TherapySemantic proximity Read ↗

The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infectionSemantic proximity Read ↗

MSC-derived exosomes carrying a cocktail of exogenous interfering RNAs an unprecedented therapy in era of COVID-19 outbreakSemantic proximity Read ↗

Differentially expressed plasmatic microRNAs in Brazilian patients with Coronavirus disease 2019 (COVID-19): preliminary resultsSemantic proximity Read ↗

How miRNAs can protect humans from coronaviruses COVID-19, SARS-CoV, and MERS-CoVSemantic proximity Read ↗

MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.